Schizophrenia spectrum
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients meeting DSM-5 criteria for schizophrenia; 2. Patients aged 18-50 years, with right handedness; 3. Junior high school or above, with IQ > 70; 4. Patients with PANSS score at most 5 in the following items: P1 delusion, P3 hallucination, P5 exaggeration, P6 suspicion/victimization, G9 abnormal thinking content; PANSS score at most 4 in the following item: P2 concept disorder; 5. Patients who are clinically stable, maintained on current antipsychotic and concomitant medications for at least 6 weeks, with no change in antipsychotic dose for at least 2 weeks. Patients must take the same type and dose of antipsychotic medications during the study period; 6. The patient and guardian sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Current severe somatic or neurological disease; 2. Current serious abnormalities in blood biochemical indicators, EEG or ECG; 3. Those who are extremely excitable, impulsive, or uncooperative; 4. Persons considered by the investigator to be at high risk of suicide or violence; 5. Those who have received electroconvulsive or magnetic stimulation therapy within six months; 6. Cochlear implant devices or other metal implants in the body; 7. Women who are pregnant or breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in subscale of Clue unfocused prospective memory combined with eye-tracking technology; | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in subscale of Matrics Consensus Cognitive Battery (MCCB) scores;Change in subscale of Positive And Negative Syndrome Scale (PANSS) scores;Adverse effects of transcranial direct current stimulation (tDCS); | — |
Countries
China
Contacts
Beijing Fengtai District Psychiatric Hospital